利用胰腺导管腺癌血清和组织来源EVs高通量miRNA测序提高诊断和预后的可预测性

核心信息

• 论文英文标题: Improved Predictability of Diagnosis and Prognosis Using Serum- and Tissue-Derived Extracellular Vesicles From Bulk mRNA Sequencing in Pancreatic Ductal Adenocarcinoma
• 期刊: Cancer Med
• 发表年份: 2025
• DOI: 10.1002/cam4.70538
• PMID/PMCID: 39812156; PMC11733676

研究概览

This study aimed to evaluate the feasibility of using exosomal miRNAs from PDAC tissues and serum as biomarkers for early detection and prognosis. MiR142-3p and miR148a-3p, alongside CA199, show promise as non-invasive biomarkers for early detection and prognosis of PDAC, improving diagnostic accuracy.

核心发现

716) in ROC curve analysis.

Gene Ontology (GO) annotations revealed that the two-miRNA panel was associated with multiple oncogenic pathways.

研究设计

Exosomes were isolated from healthy individuals and PDAC patients via tissue and serum samples, then identified by analyzing their particle size and protein content.

PDAC-specific exosomal miRNAs were identified using a microRNA array.

A large cohort was subsequently recruited to validate these findings.

Echo Biotech 角色

血清和组织外泌体分离表征&miRNA测序分析

关联平台: Exoomics®, Research Reagents & Tools

关联服务与能力: Biofluid EV Isolation & Purification, Tissue EV Isolation & Purification, EV Basic Characterization (TEM/NTA/WB), EV miRNA Profiling / Sequencing, Research Reagent / Product Supply

关联产品或试剂: Exosupur® EV Isolation/Purification Kit

参考文献

原始论文: Improved Predictability of Diagnosis and Prognosis Using Serum- and Tissue-Derived Extracellular Vesicles From Bulk mRNA Sequencing in Pancreatic Ductal Adenocarcinoma Cancer medicine. 2025. DOI: 10.1002/cam4.70538. PMID/PMCID: 39812156; PMC11733676.